Project Grant R01MH137676
Award Date
9/6/24
Completion Date
5/31/29
Dollars Obligated
$1.4M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, NY 10013, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $720,375 to New York University School of Medicine to leverage electronic health records (EHRs) and advanced data analytics to develop predictive models and identify clinical outcome subtypes for psychosis-related disorders. The key products and services to be delivered include: Building machine learning models to forecast major prognostic outcomes...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $961,668 to The Feinstein Institutes for Medical Research to leverage electronic health records, dimensional phenotyping, and genetic analyses to build predictive models and identify subtypes of clinical outcomes for individuals with schizophrenia and other psychosis-related disorders. The 5-year project aims to advance precision psychiatry by...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $779,000 to the University of Chicago to leverage electronic health records, dimensional phenotyping, and genetic analyses to develop machine learning-based predictive models and identify subtypes of clinical outcomes among individuals with schizophrenia. The award aims to advance the goals of precision psychiatry by enabling individualized...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,048,026 to The Trustees of Columbia University in the City of New York to conduct research on predicting clinical outcomes and identifying subtypes of psychosis-related disorders. The key objectives are to: 1) leverage electronic health record databases to build machine learning-based prediction models for treatment response, illness...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA 93.242 Mental Health Research Grants, is for a collaborative research project titled "PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY." The $984,036 award will be used to extend the foundational efforts of the PSYCHEMERGE network to address barriers to scalability, utility of genomic data, clinical application, and translation to clinical practice in a precision psychiatry paradigm. The key aims of the...
This Project Grant award of $334,588 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is focused on harnessing collective intelligence to predict clinical outcomes for individuals at high risk of developing psychosis. The key objectives are to: 1) Evaluate the predictive accuracy of a group of psychiatrists using clinical data individually and as a collective intelligence group, and 2) Assess the predictive performance of a...
The National Institute of Mental Health (NIMH) awarded a $845,163 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Feinstein Institutes for Medical Research. The project aims to develop a low-cost, low-burden approach that produces accurate, objective markers of psychosis severity using automated speech and language analysis. This would serve as "vital signs" for monitoring psychosis in a longitudinal clinical context. The project will first build a...
This Project Grant award of $1,217,924, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program, aims to advance precision psychiatry through a nationwide federated platform for developing generalizable and bias-aware algorithms. The key objectives include: Creating a scalable infrastructure to enable rapid multi-site training and deployment of network models for psychiatric phenotypes, predictions, and genomics analyses....
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to identify biomarkers in the cerebellar-cortical circuitry that can predict treatment response to antipsychotic medication in patients with early psychosis. The $519,558 award, which runs from June 2025 to April 2030, will enable the Feinstein Institutes for Medical Research to validate the identified predictive biomarker in a larger sample...
The National Institute of Mental Health (NIMH) awarded a $1,613,367 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to Geisinger Clinic in Danville, PA. The grant, titled "7/7-PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY", aims to address barriers to scalability, utility of genomic data, clinical application, and translation to clinical practice in a precision psychiatry paradigm. Specifically, the grant will create a nationwide federated transfer-learning...